Mir-124 rs531564 polymorphism influences genetic susceptibility to cervical cancer

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 12, 2014, Pages 5847-5851

  Wu, Henghui ^a   Zhang, Juxin ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cervical cancer; Gene polymorphism; Genetic susceptibility; MiR 124

Indexed keywords

MICRORNA 124;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGE; ALLELE; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOLOGY; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; SMOKING; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 84921470208     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. GLOBOCAN 2012: Estimated cancer incidence, mortality, and prevalence worldwide in 2012. Database: International Agency for Research on Cancer. Available at: http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx. Accessed 21 September 2014.
2. Qiao YL. Current situation of epidemiological studies on human papillomavirus infection and cervical cancer in Chinese women as well as prospects for vaccine prevention of human papillomavirus infection and cervical cancer. Chinese Journal of Epidemiology 2007; 28: 937-940.
3. Zeng L, Yu SY, Guo SQ, Yun JP, Zhang J. Identification and genotyping of oncogenic type of human papillomavirus in paraffin-embedded cervical cancer samples in Guangzhou. Nan Fang Yi Ke Da Xue Xue Bao 2009; 29: 2485-2487.
4. Ge J, Lu YX. Relation between HPV and cervical cancer as well as advance in vaccine research. Foreign Medical Sciences: Section of Virology 2005; 12: 129-129.
5. Syrjanen K. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors. Eur J Gynaecol Oncol 2008; 29: 205-221.
6. Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A 2007; 104: 3300-3305.
7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism and function. Cell 2004; 116: 281-297.
8. Srivastava K, Srivastava A. Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk. PLoS One 2012; 7: e50966.
9. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008; 3: e2557.
10. Qi L, Hu Y, Zhan Y, Wang J, Wang BB, Xia HF, Ma X. A SNP site in pri-miR-124 changes mature miR-124 expression but no contribution to Alzheimer’s disease in a Mongolian population. Neurosci Lett 2012; 515: 1-6.
11. Au WW, Sierra-Torres CH, Tyring SK. Acquired and genetic susceptibility to cervical cancer. Mutat Res 2003; 544: 361-364.
12. Wilting SM, van Boerdonk RA, Henken FE, Meijer CJ, Diosdado B, Meijer GA, le Sage C, Agami R, Snijders PJ, Steenbergene RD. Research Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer 2010; 9: 167.
13. Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med 2009; 60: 167-179.
14. Furuta M, Kozaki K, Tanaka S, Arii S, Imoto l, lnazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31: 766-776.
15. Hunt S, Jones AV, Hinsley EE, Whawell SA, Lambert DW. MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS Lett 2011; 585: 187-192.
16. Zhang J, Huang X, Xiao J, Yang Y, Zhou Y, Wang X, Liu Q, Yang J, Wang M, Qiu L, Zheng Y, Zhang P, Li J, Li J, Wang Y, Wei Q, Jin L, Wang J, Wang M. Pri-mir-124 rs531564 and pri-mir-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations. PLoS One 2014; 9: e100055.